Mannkind (MNKD) Convertible Debt (2010 - 2024)
Mannkind (MNKD) reported Convertible Debt of $36.1 million for Q4 2024, down 84.11% year-over-year from $226.9 million in Q1 2024, and down 84.18% on a QoQ basis from $227.9 million in Q3 2024.
Mannkind (MNKD) has 15 years of Convertible Debt data on file, last reported at $36.1 million in Q4 2024.
- Quarterly Convertible Debt fell 84.11% year-over-year to $36.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $36.1 million (down 84.11% YoY) and the FY2024 annual result came in at $36.1 million, down 84.11% from the prior year.
- Convertible Debt slipped to $36.1 million in Q4 2024 per MNKD's latest filing, from $227.9 million in the prior quarter.
- Across five years, Convertible Debt topped out at $227.9 million in Q3 2024 and bottomed at $5.0 million in Q1 2020.
- The 5-year median for Convertible Debt is $224.5 million (2022), against an average of $171.9 million.
- The widest annual swing landed in 2021, when Convertible Debt soared 4378.88%; it then plunged 84.11% in 2024.
- Tracing MNKD's Convertible Debt over 5 years: stood at $5.0 million in 2020, then soared by 4378.88% to $223.9 million in 2021, then advanced by 0.65% to $225.4 million in 2022, then climbed by 0.65% to $226.9 million in 2023, then sank by 84.11% to $36.1 million in 2024.
- Per Business Quant, the three latest MNKD Convertible Debt figures stand at $36.1 million (Q4 2024), $227.9 million (Q3 2024), and $227.6 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 36.05 Mn |
| Sep 30, 2024 | 227.94 Mn |
| Jun 30, 2024 | 227.58 Mn |
| Mar 31, 2024 | 227.21 Mn |
| Dec 31, 2023 | 226.85 Mn |
| Sep 30, 2023 | 226.49 Mn |
| Jun 30, 2023 | 226.12 Mn |
| Mar 31, 2023 | 225.76 Mn |
| Dec 31, 2022 | 225.40 Mn |
| Sep 30, 2022 | 225.03 Mn |
| Jun 30, 2022 | 224.67 Mn |
| Mar 31, 2022 | 224.31 Mn |
| Dec 31, 2021 | 223.94 Mn |
| Sep 30, 2021 | 223.58 Mn |
| Jun 30, 2021 | 223.22 Mn |
| Mar 31, 2021 | 222.86 Mn |
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 5.00 Mn |
| Jun 30, 2020 | 5.00 Mn |
| Mar 31, 2020 | 5.00 Mn |
| Dec 31, 2019 | 5.00 Mn |
| Sep 30, 2019 | 7.44 Mn |
| Jun 30, 2019 | 19.03 Mn |
| Mar 31, 2019 | 19.07 Mn |
| Dec 31, 2018 | 19.10 Mn |
| Sep 30, 2018 | 19.13 Mn |
| Jun 30, 2018 | 19.16 Mn |
| Mar 31, 2018 | 24.37 Mn |
| Dec 31, 2017 | 24.41 Mn |
| Sep 30, 2017 | 27.66 Mn |
| Jun 30, 2017 | 27.65 Mn |
| Mar 31, 2017 | 27.64 Mn |
| Dec 31, 2016 | 27.64 Mn |
| Sep 30, 2016 | 27.63 Mn |
| Jun 30, 2016 | 27.62 Mn |
| Mar 31, 2016 | 27.62 Mn |
| Dec 31, 2015 | 27.61 Mn |
| Sep 30, 2015 | 27.61 Mn |
| Jun 30, 2015 | 35.71 Mn |
| Jun 30, 2014 | 98.89 Mn |
| Mar 31, 2014 | 98.66 Mn |
| Dec 31, 2013 | 98.44 Mn |
| Sep 30, 2013 | 98.22 Mn |
| Jun 30, 2013 | 98.00 Mn |
| Mar 31, 2013 | 97.79 Mn |
| Dec 31, 2012 | 212.03 Mn |
| Sep 30, 2012 | 211.67 Mn |
| Jun 30, 2012 | 211.18 Mn |
| Mar 31, 2012 | 210.95 Mn |
| Dec 31, 2011 | 210.64 Mn |
| Sep 30, 2011 | 210.31 Mn |
| Jun 30, 2011 | 209.98 Mn |
| Dec 31, 2010 | 209.34 Mn |